APA (7th ed.) Citation

J, C., DJ, J., TB, C., L, B., KF, R., WW, B., . . . Y, D. (2023, March). Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization. Journal of Asthma and Allergy.

Chicago Style (17th ed.) Citation

J, Corren, et al. "Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization." Journal of Asthma and Allergy Mar. 2023.

MLA (9th ed.) Citation

J, Corren, et al. "Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization." Journal of Asthma and Allergy, Mar. 2023.